Trending Now
Curis, Inc. (NASDAQ: CRIS) Recently Announced Its Partners’ Publication on Emarvusatib
Curis, Inc. (NASDAQ: CRIS) recently announced the publication of a report created by the company's collaborators. The school of Medicine from Washington University authored...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Wave Life Sciences ($WVE) Achieves Groundbreaking Success in RNA Editing for...
In a landmark advancement in biotechnology, Wave Life Sciences Ltd. (Nasdaq: WVE), headquartered in Cambridge, Massachusetts, has announced compelling results from its...
MAKE IT MODERN
LATEST REVIEWS
Aptevo Therapeutics Inc. (NASDAQ:APVO) Receives Royalty For RUXIENCE From Pfizer Inc....
Aptevo Therapeutics Inc. (NASDAQ:APVO) received royalty payments from Pfizer Inc. (NYSE:PFE) on sales of rituximab biosimilar product (RUXIENCE).
The FDA approved RUXIENCE in July last...
MAKE IT MODERN
PERFORMANCE TRAINING
The Rebirth of ISW Holdings Inc (OTCMKTS:ISWH)
Some stocks get fresh chances. Those are interesting opportunities in many cases because market participants are slow to grant them a new...
Innoviva Inc. Submits Proposal To Acquire All Outstanding Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX)...
Entasis Therapeutics Holdings Inc.’s (NASDAQ: ETTX) Board of Directors has received an interim, non-binding proposal from Innoviva Inc., its majority shareholder, to purchase all...
Four Stocks for the Weight Loss Crisis (MED, WW, MCTC, PLNT)
Today’s topic is pretty heavy. But the stocks involved certainly aren’t. As more and more Americans bust their belts during stay-at-home virus life, stocks...
Moderna (NASDAQ:MRNA) To File Emergency Use Authorization For Its COVID-19 Vaccine After Encouraging Final...
Moderna (NASDAQ:MRNA) has released additional encouraging data for its COVID-19 vaccine showing that the vaccine is 94.1% effective in protecting against serious illness. Two...
InflaRx (NASDAQ:IFRX) Commence Phase III Study Of IFX-1 In Treatment Of Severe COVID-19 Induced...
InflaRx (NASDAQ:IFRX) has announced the third phase of Phase II/III study with IFX-1 in severe coronavirus induced pneumonia. The company initiated the first enrolment...
MAKE IT MODERN
